{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:37:22Z","timestamp":1778276242824,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s13318-020-00606-8","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T20:03:52Z","timestamp":1580414632000},"page":"393-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["1-(Benzo[b]thiophen-4-yl)piperazine Ring Induced Bioactivation of Brexpiprazole in Liver Microsomes: Identification and Characterization of Reactive Conjugates Using Ultra-High-Performance Liquid Chromatography\/Quadrupole Time-of-Flight Mass Spectrometry"],"prefix":"10.1007","volume":"45","author":[{"given":"Disha","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0500-488X","authenticated-orcid":false,"given":"Abhijeet S.","family":"Kate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"issue":"4","key":"606_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40263-016-0325-8","volume":"30","author":"KP Garnock-Jones","year":"2016","unstructured":"Garnock-Jones KP. Brexpiprazole: a review in schizophrenia. CNS Drugs. 2016;30(4):335\u201342. https:\/\/doi.org\/10.1007\/s40263-016-0325-8.","journal-title":"CNS Drugs"},{"issue":"2","key":"606_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40263-016-0320-0","volume":"30","author":"K McKeage","year":"2016","unstructured":"McKeage K. Adjunctive brexpiprazole: a review in major depressive disorder. CNS Drugs. 2016;30(2):91\u20139. https:\/\/doi.org\/10.1007\/s40263-016-0320-0.","journal-title":"CNS Drugs"},{"issue":"14","key":"606_CR3","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s40265-015-0462-2","volume":"75","author":"SL Greig","year":"2015","unstructured":"Greig SL. Brexpiprazole: first global approval. Drugs. 2015;75(14):1687\u201397. https:\/\/doi.org\/10.1007\/s40265-015-0462-2.","journal-title":"Drugs"},{"issue":"58","key":"606_CR4","doi-asserted-by":"publisher","first-page":"36279","DOI":"10.1039\/C7RA06341E","volume":"7","author":"AA Kadi","year":"2017","unstructured":"Kadi AA, Amer SM, Darwish HW, Attwa MW. LC-MS\/MS reveals the formation of aldehydes and iminium reactive intermediates in foretinib metabolism: phase I metabolic profiling. RSC Adv. 2017;7(58):36279\u201387. https:\/\/doi.org\/10.1039\/C7RA06341E.","journal-title":"RSC Adv"},{"issue":"3","key":"606_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/1389200054021799","volume":"6","author":"AS Kalgutkar","year":"2005","unstructured":"Kalgutkar AS, Gardner I, Obach RS, Shaffer CL, Callegari E, Henne KR, et al. A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab. 2005;6(3):161\u2013225. https:\/\/doi.org\/10.2174\/1389200054021799.","journal-title":"Curr Drug Metab"},{"issue":"11","key":"606_CR6","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/cbdv.200900055","volume":"6","author":"AS Kalgutkar","year":"2009","unstructured":"Kalgutkar AS, Didiuk MT. Structural alerts, reactive metabolites, and protein covalent binding: how reliable are these attributes as predictors of drug toxicity? Chem Biodivers. 2009;6(11):2115\u2013377. https:\/\/doi.org\/10.1002\/cbdv.200900055.","journal-title":"Chem Biodivers"},{"issue":"6","key":"606_CR7","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1124\/dmd.108.020545","volume":"36","author":"JN Bauman","year":"2008","unstructured":"Bauman JN, Frederick KS, Sawant A, Walsky RL, Cox LM, Obach RS, et al. Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug. Drug Metab Dispos. 2008;36(6):1016\u201329. https:\/\/doi.org\/10.1124\/dmd.108.020545.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"606_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bbrc.2005.08.091","volume":"338","author":"PM Dansette","year":"2005","unstructured":"Dansette PM, Bertho G, Mansuy D. First evidence that cytochrome P450 may catalyze both S-oxidation and epoxidation of thiophene derivatives. Biochem Biophys Res Commun. 2005;338(1):450\u20135. https:\/\/doi.org\/10.1016\/j.bbrc.2005.08.091.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"606_CR9","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1021\/tx500134g","volume":"27","author":"D Gramec","year":"2014","unstructured":"Gramec D, Peterlin Ma\u0161i\u010d L, Sollner DM. Bioactivation potential of thiophene-containing drugs. Chem Res Toxicol. 2014;27(8):1344\u201358. https:\/\/doi.org\/10.1021\/tx500134g.","journal-title":"Chem Res Toxicol"},{"issue":"20","key":"606_CR10","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1021\/ja00020a089","volume":"113","author":"D Mansuy","year":"1991","unstructured":"Mansuy D, Valadon P, Erdelmeier I, Lopez-Garcia P, Amar C, Girault JP, et al. Thiophene S-oxides as new reactive metabolites: formation by cytochrome P-450 dependent oxidation and reaction with nucleophiles. J Am Chem Soc. 1991;113(20):7825\u20136. https:\/\/doi.org\/10.1021\/ja00020a089.","journal-title":"J Am Chem Soc"},{"issue":"9","key":"606_CR11","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1124\/dmd.109.027524","volume":"37","author":"S Shimizu","year":"2009","unstructured":"Shimizu S, Atsumi R, Nakazawa T, Fujimaki Y, Sudo K, Okazaki O. Metabolism of ticlopidine in rats: identification of the main biliary metabolite as a glutathione conjugate of ticlopidine s-oxide. Drug Metab Dispos. 2009;37(9):1904\u201315. https:\/\/doi.org\/10.1124\/dmd.109.027524.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"606_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jms.3170","volume":"48","author":"F Du","year":"2013","unstructured":"Du F, Ruan Q, Zhu M, Xing J. Detection and characterization of ticlopidine conjugates in rat bile using high-resolution mass spectrometry: applications of various data acquisition and processing tools. J Mass Spectrom. 2013;48(3):413\u201322. https:\/\/doi.org\/10.1002\/jms.3170.","journal-title":"J Mass Spectrom"},{"issue":"12","key":"606_CR13","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1021\/ci400518g","volume":"53","author":"J Zaretzki","year":"2013","unstructured":"Zaretzki J, Matlock M, Swamidass SJ. XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks. J Chem Inf Model. 2013;53(12):3373\u201383. https:\/\/doi.org\/10.1021\/ci400518g.","journal-title":"J Chem Inf Model"},{"issue":"7","key":"606_CR14","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/bioinformatics\/btu761","volume":"31","author":"MK Matlock","year":"2014","unstructured":"Matlock MK, Hughes TB, Swamidass SJ. XenoSite server: a web-available site of metabolism prediction tool. Bioinformatics. 2014;31(7):1136\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btu761.","journal-title":"Bioinformatics"},{"key":"606_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.8436","author":"D Thakkar","year":"2019","unstructured":"Thakkar D, Kate AS. In silico, in vitro and in vivo metabolite identification of brexpiprazole using ultra high performance liquid chromatography-quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 2019. https:\/\/doi.org\/10.1002\/rcm.8436.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"606_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clinms.2017.11.001","volume":"6","author":"JR Enders","year":"2017","unstructured":"Enders JR, Reddy SG, Strickland EC, McIntire GL. Identification of metabolites of brexpiprazole in human urine for use in monitoring patient compliance. Clin Mass Spectrom. 2017;6:21\u20134. https:\/\/doi.org\/10.1016\/j.clinms.2017.11.001.","journal-title":"Clin Mass Spectrom"},{"issue":"7","key":"606_CR17","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1021\/acs.chemrestox.8b00023","volume":"31","author":"J Zhu","year":"2018","unstructured":"Zhu J, Wang P, Shehu AI, Lu J, Bi H, Ma X. Identification of novel pathways in idelalisib metabolism and bioactivation. Chem Res Toxicol. 2018;31(7):548\u201355. https:\/\/doi.org\/10.1021\/acs.chemrestox.8b00023.","journal-title":"Chem Res Toxicol"},{"issue":"11","key":"606_CR18","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1021\/acs.chemrestox.6b00242","volume":"29","author":"J Chen","year":"2016","unstructured":"Chen J, Peng Y, Zheng J. Cytochrome P450 mediated bioactivation of saracatinib. Chem Res Toxicol. 2016;29(11):1835\u201342. https:\/\/doi.org\/10.1021\/acs.chemrestox.6b00242.","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"606_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.trac.2010.10.014","volume":"30","author":"B Prasad","year":"2011","unstructured":"Prasad B, Garg A, Takwani H, Singh S. Metabolite identification by liquid chromatography-mass spectrometry. Trends Analyt Chem. 2011;30(2):360\u201387. https:\/\/doi.org\/10.1016\/j.trac.2010.10.014.","journal-title":"Trends Analyt Chem"},{"issue":"7","key":"606_CR20","first-page":"418","volume":"41","author":"S Eaves","year":"2016","unstructured":"Eaves S, Rey JA. Brexpiprazole (Rexulti): a new monotherapy for schizophrenia and adjunctive therapy for major depressive disorder. P & T Peer-Rev J Formul Manag. 2016;41(7):418\u201322.","journal-title":"P & T Peer-Rev J Formul Manag"},{"issue":"4","key":"606_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3371\/csrp.mcci.010316","volume":"9","author":"J McEvoy","year":"2016","unstructured":"McEvoy J, Citrome L. Brexpiprazole for the treatment of schizophrenia: a review of this novel serotonin-dopamine activity modulator. Clin Schizophr Relat Psychoses. 2016;9(4):177\u201386. https:\/\/doi.org\/10.3371\/csrp.mcci.010316.","journal-title":"Clin Schizophr Relat Psychoses"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-020-00606-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-020-00606-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-020-00606-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:07:02Z","timestamp":1611878822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-020-00606-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1007\/s13318-020-00606-8","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]},"assertion":[{"value":"30 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The study was funded by\u00a0research fellowship provided by the\u00a0Department of Pharmaceuticals, Ministry of Chemical and Fertilizer, New Delhi, India.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Disha Thakkar and Abhijeet S. Kate have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}